Tata Institute Claims Big Breakthrough In Cancer Treatment
NDTV
The Tata Memorial Centre (TMC) in research said dying cancer cells release cell-free chromatin particles (cfChPs, or fragments of chromosomes) which can turn healthy cells into cancerous ones.
The Tata Institute in Mumbai, a premier cancer research and treatment institute in India, has claimed to have discovered a treatment that can prevent the resurgence of cancer the second time.
The researchers and doctors at the institute worked for ten years and have now developed a tablet which they claim would prevent the occurrence of cancer for the second time in patients and will also reduce the side effects of treatments like radiation and chemotherapy by 50 per cent.
Speaking to NDTV, Dr Rajendra Badve, a senior cancer surgeon at Tata Memorial Hospital, who was part of the research group, said, "Human cancer cells were inserted in rats for the research, which formed a tumour in them. The rats were then treated with radiation therapy, chemotherapy and surgery. It was found that when these cancer cells die, they break into tiny pieces called Chromatin particles. These particles can travel to other parts of the body through the bloodstream and when they enter healthy cells, they can turn them cancerous."
